Cargando…
Using common genetic variants to find drugs for common epilepsies
Better drugs are needed for common epilepsies. Drug repurposing offers the potential of significant savings in the time and cost of developing new treatments. In order to select the best candidate drug(s) to repurpose for a disease, it is desirable to predict the relative clinical efficacy that drug...
Autores principales: | Mirza, Nasir, Stevelink, Remi, Taweel, Basel, Koeleman, Bobby P C, Marson, Anthony G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710935/ https://www.ncbi.nlm.nih.gov/pubmed/34988442 http://dx.doi.org/10.1093/braincomms/fcab287 |
Ejemplares similares
-
A systems medicine strategy to predict the efficacy of drugs for monogenic epilepsies
por: Taweel, Basel, et al.
Publicado: (2022) -
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy
por: Schijven, Dick, et al.
Publicado: (2020) -
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
por: Wolking, Stefan, et al.
Publicado: (2021) -
Assessing the genetic association between vitamin B6 metabolism and genetic generalized epilepsy
por: Stevelink, Remi, et al.
Publicado: (2019) -
Assessing the role of rare genetic variants in drug‐resistant, non‐lesional focal epilepsy
por: Wolking, Stefan, et al.
Publicado: (2021)